Cargando…

Effects of obesity and 10 weeks metformin treatment on liver steatosis

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of liver disease in adolescents and adults, and the risk of developing NAFLD increases with obesity. In the present study, it was shown that obesity increased fatty liver (steatosis) using an obese Zucker rat model. Metformin is an oral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hakkak, Reza, Rose, Shannon, Spray, Beverly, Kozaczek, Melisa, Korourian, Soheila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042663/ https://www.ncbi.nlm.nih.gov/pubmed/33859820 http://dx.doi.org/10.3892/br.2021.1425

Ejemplares similares

Diet Containing Soy Protein Concentrate With Low and High Isoflavones for 9 Weeks Protects Against Non-alcoholic Fatty Liver Steatosis Using Obese Zucker Rats
por: Hakkak, Reza, et al.
Publicado: (2022)

Diet Containing Soy Protein Concentrate with Low and High Isoflavones for 18 Weeks Protects Against Non-alcoholic Fatty Liver Diseases
por: Hakkak, Reza, et al.
Publicado: (2022)

Effects of 8 Weeks Feeding Diet with Low and High Isoflavones Soy Protein Concentrate on Serum Isoflavones in Non-alcoholic Fatty Liver Disease (NAFLD) Rat Model
por: Hakkak, Reza, et al.
Publicado: (2022)

Dehydroepiandrosterone (DHEA) Feeding Protects Liver Steatosis in Obese Breast Cancer Rat Model
por: Hakkak, Reza, et al.
Publicado: (2017)

Short-Term Soy Protein Isolate Feeding Prevents Liver Steatosis and Reduces Serum ALT and AST Levels in Obese Female Zucker Rats
por: Hakkak, Reza, et al.
Publicado: (2018)

Long-Term Soy Protein Isolate Consumption Reduces Liver Steatosis Through Changes in Global Transcriptomics in Obese Zucker Rats
por: Kozaczek, Melisa, et al.
Publicado: (2020)

Effects of Short- and Long-Term Soy Protein Feeding on Hepatic Cytochrome P450 Expression in Obese Nonalcoholic Fatty Liver Disease Rat Model
por: Kozaczek, Melisa, et al.
Publicado: (2021)

Short-Term Metformin Treatment Enriches Bacteroides dorei in an Obese Liver Steatosis Zucker Rat Model
por: Robeson, Michael S., et al.
Publicado: (2022)

Effects of Obesity on Pro-Oxidative Conditions and DNA Damage in Liver of DMBA-Induced Mammary Carcinogenesis Models
por: Melnyk, Stepan, et al.
Publicado: (2017)

Assessment of gut microbiota populations in lean and obese Zucker rats
por: Hakkak, Reza, et al.
Publicado: (2017)

Effect of Metformin Treatment on Serum Metabolic Profile Changes in Lean and Obese Zucker Rat Model for Fatty Liver Disease
por: Melnyk, Stepan, et al.
Publicado: (2023)

Obesity promotes 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in female zucker rats
por: Hakkak, Reza, et al.
Publicado: (2005)

Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
por: Li, Min, et al.
Publicado: (2017)

Metformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
por: Riemann, Annika, et al.
Publicado: (2022)

Short treatment of metformin attenuated insulin resistance and hepatic steatosis in obese mice by mechanisms independents of PPAR-alpha
por: Teixeira, Alexandre, et al.
Publicado: (2014)

The Beneficial Additive Effect of Silymarin in Metformin Therapy of Liver Steatosis in a Pre-Diabetic Model
por: Hüttl, Martina, et al.
Publicado: (2021)

Metformin Ameliorates Hepatic Steatosis and Inflammation without Altering Adipose Phenotype in Diet-Induced Obesity
por: Woo, Shih-Lung, et al.
Publicado: (2014)

Effect of mitoquinone on liver metabolism and steatosis in obese and diabetic rats
por: Fink, Brian D., et al.
Publicado: (2021)

Senescence explains age- and obesity-related liver steatosis
por: Ogrodnik, Mikolaj, et al.
Publicado: (2017)

Gut Microbiota Reshaped by Pectin Treatment Improves Liver Steatosis in Obese Mice
por: Houron, Camille, et al.
Publicado: (2021)

Metabolic Status of Lean and Obese Zucker Rats Based on Untargeted and Targeted Metabolomics Analysis of Serum
por: Melnyk, Stepan, et al.
Publicado: (2022)

The Promyelocytic Leukemia Protein Is Upregulated in Conditions of Obesity and Liver Steatosis
por: Carracedo, Arkaitz, et al.
Publicado: (2015)

Predictive Role of Interleukin-18 in Liver Steatosis in Obese Children
por: Flisiak-Jackiewicz, Marta, et al.
Publicado: (2018)

Effects of Metformin on Hepatic Steatosis in Adults with Nonalcoholic Fatty Liver Disease and Diabetes: Insights from the Cellular to Patient Levels
por: Pinyopornpanish, Kanokwan, et al.
Publicado: (2021)

Dietary walnut oil modulates liver steatosis in the obese Zucker rat
por: Fink, Anja, et al.
Publicado: (2013)

Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis
por: Di Palo, Domenica Maria, et al.
Publicado: (2020)

Insulin Clearance at the Pubertal Transition in Youth with Obesity and Steatosis Liver Disease
por: Franceschi, Roberto, et al.
Publicado: (2023)

Long-Term Effectiveness and Safety of Once Weekly Dulaglutide as Add-on to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes
por: Mirabelli, Maria, et al.
Publicado: (2021)

Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis
por: Salic, Kanita, et al.
Publicado: (2019)

Non-contrasted Computed Tomography for the Accurate Measurement of Liver Steatosis in Obese Patients
por: Shores, Nathan J., et al.
Publicado: (2011)

Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies
por: Baldini, Francesca, et al.
Publicado: (2022)

Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein
por: LIU, FANG, et al.
Publicado: (2014)

Effect of Vitamin E and Metformin on Fatty Liver Disease in Obese Children- Randomized Clinical Trial
por: SHIASI ARANI, Kobra, et al.
Publicado: (2014)

Liraglutide reduces attenuation coefficient as a measure of hepatic steatosis during 16 weeks' treatment in nondiabetic obese patients: A pilot trial
por: Wang, Xiao Jing, et al.
Publicado: (2020)

Reduced Liver Autophagy in High-Fat Diet Induced Liver Steatosis in New Zealand Obese Mice
por: Korovila, Ioanna, et al.
Publicado: (2021)

A Pilot Study Protocol: Glycemic Patterns in Obese Pregnancies Without Diabetes – Identifying Susceptible Periods for Intervention
por: Jansen, Lisa, et al.
Publicado: (2022)

Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats
por: Aguirre, Leixuri, et al.
Publicado: (2019)

Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling
por: Suga, Takayoshi, et al.
Publicado: (2020)

Fat mass and obesity–associated protein promotes liver steatosis by targeting PPARα
por: Wei, Xiaohui, et al.
Publicado: (2022)

Controlled attenuation parameters to assess liver steatosis in obese patients with polycystic ovary syndrome
por: Wang, Dongxu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t9fu7ts4qe96nm2u39v43a7mbr